If the claim holds up, personalized phage therapy could become a new frontline weapon against antibiotic resistance - but proof is far from final.

Revolut, Halifax, and Emma went dark Tuesday as Google's London cloud region failed. Here's what it means for fintech's reliance on Big Tech infrastructure.

A final call from Beijing puts high-net-worth individuals on notice: declare offshore trust gains by October 22 or face penalties, with ripple effects for Hong Kong's wealth hub.

An LA restaurant group's Kalshi trade paid off when the Dodgers lost, and small businesses are flocking to prediction markets to hedge everything from playoff runs to cold fronts.

The journalist who exposed Theranos says the Oscar-buzzed film is art, not evidence, and the distinction matters for anyone weighing a founder's story.

A court filing says a Saudi military official funded the family's exit and Riyadh offered bail, putting foreign-influence risk squarely on AI boards.

OpenAI's AI proved a weaker version of the biggest open question in math, and human experts have already unpacked it.

The Claude maker's 5% share pledge, worth $48bn, is a bid to win over regulators and investors before its stock market listing.

A Savannah officer's shared credential let an ICE agent run hundreds of plate searches on Hispanic drivers, exposing a surveillance backdoor.

Alan Milburn's call for welfare cuts to fund employment support opens a Labour fight over benefits and the Neet crisis.

The chatbot startup's collapse hands Disney a ready-made AI team, with ex-CEO Karandeep Anand already installed as the entertainment giant's first CTO.

Woodside's Scarborough gas project is frozen mid-start-up after activists boarded the platform, a disruption with cost and reputational ripple effects for LNG operators.